You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

35 search results for: long-term

expert video

Assessing EoE: Assessing Symptoms in Patients With EoE

6 min

Gastroenterology

Join Dr. Nirmala Gonsalves as she reviews symptoms of EoE and tools to assess symptoms in patients with EoE.

expert video

UEGW 2023 | Burden of EoE and Multidimensional Assessment of Disease

10 min

Gastroenterology

Dr. Christoper Ma explores the burden of disease in EoE and the multiple dimensions of disease to assess in patients with EoE.

expert video

CRSwNP: A Chronic Type 2 Inflammatory Disease

2 min

Rhinology

Prof. Peter Hellings describes how type 2 inflammation drives CRSwNP.

expert video

UEGW 2023 | Biologics in EoE

16 min

Gastroenterology

Prof. Christoph Schlag presents the latest clinical data for biologics in EoE.

expert video

UEGW 2023 | How Do You and Your Patient Decide What Is Best for Managing Their EoE?

8 min

Gastroenterology

Prof. Christoph Schlag and Dr. Christopher Ma discuss their approaches to treatment decisions and maintenance therapy for their patients with EoE.

expert video

UEGW 2023 | How Do You Individualize the Approach to Assessing EoE?

9 min

Gastroenterology

Prof. Christoph Schlag and Dr. Christopher Ma discuss their approaches to assessing patients with EoE and how they define disease control.

Infographic

Adaptive Behaviors in EoE Infographic

5 min

Gastroenterology

Learn how to recognize adaptive eating behaviors in patients with EoE and why it is important for assessment and management.

expert video

Scientific Advances in EoE and Impact on Clinical Practice

30 min

Gastroenterology

Expert gastroenterologist Dr. Evan Dellon highlights research and scientific advances in EoE and their impact on clinical practice.

interactivity

Piecing Together the Puzzle in Patients With EoE

5 min

Gastroenterology

In this hypothetical EoE patient case, learn about the different disease domains that are important in seeing the complete patient picture in EoE.

expert video

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

11 min

Gastroenterology

Dr. Milli Gupta emphasizes the need to regularly monitor multiple disease domains when assessing treatment response, not just EoE symptoms.

Podcast

ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD

23 min

Dermatology

Join Drs. April Armstrong and Lisa Beck for a conversation around the long-term burden and effects of AD. They will discuss the underlying pathophysiology of AD and how early intervention and disease modification may impact disease course.

expert video

Current and Emerging Therapeutic Options for Children With Atopic Dermatitis

16 min

Dermatology

In this video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang reviews the current and emerging treatment options for children with AD uncontrolled with topical therapy, including a summary of recent long-term data for advanced systemic therapies

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: BelgiumChange country/region